4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-17-061592
SVP & Chief Financial Officer returned 6,698 shares (to the company)
- SVP & Chief Financial Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Labrucherie Gil M · SVP & Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-15 | Grant or award : show line 1 in the form | +20,000 | 83,414 | D | ||
| 2017-11-16 | Returned to the company : show line 2 in the form | −6,698 | $44.23 | $296,253 | 76,716 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-15 | Grant or award : show line 3 in the form Stock Option | +50,000 | 50,000 | D |
Loading xslF345X03/doc4.xml…